Section Lot 8009.08 - Additional Rules Regarding Erythropoietin, Darbepoietin and Analogous Substances(a) "Screening test" means a preliminary test designed to determine that a substance prohibited by these rules is not present.(b) No horse shall race if that horse has within its system:(1) The substances known as erythropoietin or darbepoietin, except to the extent that those substances occur naturally within the horse's bodily system; or(2) Any substance analogous to those specified in (b) (1) above that causes an artificial increase in red blood cells in a horse.(c) In the case of a violation of these rules relative to erythropoietin or darbepoietin, the penalty provisions of Lot 8003.03 or Lot 8009.04 shall not apply if, and only if, the sole basis for imposing the penalty would be that a screening test of blood or urine fails to rule out the possibility that a horse may have run contrary to (b) above.(d) A horse that has been subject to a screening test of blood or urine that fails to rule out the presence of erythropoietin or darbepoietin or an analogous substance as described in (b) (2) above shall not race again until such time as a test conducted by the approved laboratory services for the commission of blood samples, or serum or plasma samples obtained from blood, collected from the horse confirms the absence of those substances from the horse's system.(e) Tests conducted under (d) above shall be at the expense of the owner or trainer of the horse tested.(f) This section shall not apply to hemoglobin glutamers, such as the substances known as Oxyglobin or Hemopure, which shall be addressed as set forth in Lot 8009.03 and Lot 8009.04.N.H. Admin. Code § Lot 8009.08
Derived From Volume XXXVIII Number 23, Filed June 7, 2018, Proposed by #12544, Effective 6/1/2018, Expires 6/1/2028.